ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Clinical trials evaluating the management of acute exacerbations of COPD assess
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
ERS Statement: A core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations
AG Mathioudakis, F Abroug, A Agusti, S Ananth… - 2021 - christie.openrepository.com
Clinical trials evaluating the management of acute exacerbations of COPD assess
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations.
AG Mathioudakis, F Abroug, A Agusti… - The European …, 2022 - europepmc.org
Clinical trials evaluating the management of acute exacerbations of COPD assess
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
ERS Statement: A core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations
AG Mathioudakis, F Abroug, A Agusti… - European …, 2022 - openaccess.sgul.ac.uk
Clinical trials evaluating the management of acute exacerbations of COPD assess
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
AG Mathioudakis, F Abroug, A Agusti… - The European …, 2022 - pubmed.ncbi.nlm.nih.gov
Clinical trials evaluating the management of acute exacerbations of COPD assess
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
[引用][C] ERS statement: A core outcome set for clinical trials evaluating the management of COPD exacerbations
AG Mathioudakis, A Bikov, J Vestbo, F Abroug… - European Respiratory …, 2022 - elibrary.ru
ERS statement: a core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations
AG Mathioudakis, F Abroug, A Agusti… - EUROPEAN …, 2022 - biblio.ugent.be
Clinical trials evaluating the management of acute exacerbations of COPD assess
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
ERS Statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
AG Mathioudakis, F Abroug, A Agusti… - The European …, 2022 - research.regionh.dk
Clinical trials evaluating the management of acute exacerbations of COPD assess
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
[引用][C] ERS Statement: A core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations.
A Mathioudakis, A Bikov, J Yorke… - The European …, 2021 - research.manchester.ac.uk
ERS Statement: A core outcome set for clinical trials evaluating the management of chronic
obstructive pulmonary disease (COPD) exacerbations. — Research Explorer The University …
obstructive pulmonary disease (COPD) exacerbations. — Research Explorer The University …
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
AG Mathioudakis, F Abroug, A Agusti, S Ananth… - Eur Respir …, 2022 - Eur Respiratory Soc
Clinical trials evaluating the management of acute exacerbations of COPD assess
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
heterogeneous outcomes, often omitting those that are clinically relevant or more important …